Marc Pfister
Overview
Explore the profile of Marc Pfister including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
146
Citations
1250
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Steffens B, Koch G, Engel C, Franz A, Pfister M, Wellmann S
Front Digit Health
. 2025 Mar;
7:1497165.
PMID: 40041127
Background: Neonatal jaundice affects more than half of neonates. As bilirubin values usually peak few days after hospital discharge, jaundice remains a leading cause of rehospitalization. The recently developed BiliPredics...
2.
Ravix A, Gotta V, Pfister M, Berger C, Glauser A, Paioni P, et al.
J Clin Pharmacol
. 2025 Jan;
PMID: 39866024
Amoxicillin is commonly used to treat erythema migrans in the first stage of Lyme disease in children, with a recommended dose of 50 mg/kg/day, administered three times a day (q8h)....
3.
Bram D, Bachmann F, Schropp J, Gotta V, Steffens B, van den Anker J, et al.
J Clin Pharmacol
. 2025 Jan;
PMID: 39828967
Understanding drug dosing to fulfill safety and efficacy requirements in a patient population is an essential part of dose finding in clinical practice and drug development. The majority of current...
4.
Mueller A, Pfister M, Faes Hesse M, Zingg W, Wolfensberger A
Clin Microbiol Infect
. 2024 Nov;
PMID: 39581542
Objectives: Semi-automated surveillance systems save time compared with traditional manual methods, particularly for non-ventilator hospital-acquired pneumonia (nvHAP), a nosocomial infection which can affect all non-intubated patients. In semi-automated surveillance, a...
5.
Bram D, Steiert B, Pfister M, Steffens B, Koch G
CPT Pharmacometrics Syst Pharmacol
. 2024 Nov;
14(1):5-16.
PMID: 39552211
Neural ordinary differential equations (NODEs) are an emerging machine learning (ML) method to model pharmacometric (PMX) data. Combining mechanism-based components to describe "known parts" and neural networks to learn "unknown...
6.
Leutheuser H, Bartholet M, Marx A, Pfister M, Burckhardt M, Bachmann S, et al.
Front Med (Lausanne)
. 2024 Nov;
11:1439218.
PMID: 39526244
Children with type 1 diabetes (T1D) frequently have nocturnal hypoglycemia, daytime physical activity being the most important risk factor. The risk for late post-exercise hypoglycemia depends on various factors and...
7.
Ajayi D, Orherhe O, Pillai G, Mouksassi S, Steffens B, Bram D, et al.
J Clin Pharmacol
. 2024 Nov;
PMID: 39506211
The efficacy of the combination therapy of albendazole and ivermectin against Trichuris trichiura infection is higher in Tanzania than in Côte d'Ivoire. This study therefore aimed to investigate the difference...
8.
Bachmann F, Koch G, Bauer R, Steffens B, Szinnai G, Pfister M, et al.
J Pharmacokinet Pharmacodyn
. 2024 Oct;
51(6):919-934.
PMID: 39377900
Recently, an optimal dosing algorithm (OptiDose) was developed to compute the optimal drug doses for any pharmacometrics model for a given dosing scenario. In the present work, we enhance the...
9.
Golhen K, Buettcher M, Huwyler J, van den Anker J, Gotta V, Dao K, et al.
Pharmaceutics
. 2024 Sep;
16(9).
PMID: 39339222
The antiparasitic drug ivermectin is approved for persons > 15 kg in the US and EU. A pharmacometric (PMX) population model with clinical PK data was developed (i) to characterize...
10.
Gavel G, Koch G, Terrier A, Atkinson A, Pfister M, Erb T
Paediatr Anaesth
. 2024 Jul;
34(10):1019-1028.
PMID: 39082130
Background: The pharmacodynamics of propofol in children have previously been described with the proprietary bispectral index (BIS) as an effect-site marker, and it has been suggested that the rate of...